Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 2.80 -0.03 (1.06%)
Previous Close $2.83    52 Week High $3.05 
Open $2.82    52 Week Low $0.49 
Day High $2.99    P/E N/A 
Day Low $2.78    EPS $-1.32 
Volume 260,643